PMID- 30975686
OWN - NLM
STAT- MEDLINE
DCOM- 20200508
LR  - 20200508
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 9
IP  - 4
DP  - 2019 Apr 11
TI  - Cost and cost-effectiveness of mHealth interventions for the prevention and 
      control of type 2 diabetes mellitus: a protocol for a systematic review.
PG  - e027490
LID - 10.1136/bmjopen-2018-027490 [doi]
LID - e027490
AB  - INTRODUCTION: Type 2 diabetes mellitus (T2DM) remains one of the most common 
      chronic diseases of adulthood which creates high degrees of morbidity and 
      mortality worldwide. The incidence of T2DM continues to rise and recently, 
      mHealth interventions have been increasingly used in the prevention, monitoring 
      and management of T2DM. The aim of this study is to systematically review the 
      published evidence on cost and cost-effectiveness of mHealth interventions for 
      T2DM, as well as assess the quality of reporting of the evidence. METHODS AND 
      ANALYSIS: A comprehensive review of PubMed, EMBASE, Science Direct and Web of 
      Science of articles published until January 2019 will be conducted. Included 
      studies will be partial or full economic evaluations which provide cost or 
      cost-effectiveness results for mHealth interventions targeting individuals 
      diagnosed with, or at risk of, T2DM. The quality of reporting evidence will be 
      assessed using the Consolidated Health Economic Evaluation Reporting Standards 
      (CHEERS) checklist. Results will be presented using a flowchart following the 
      Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols 
      (PRISMA-P) guidelines. Graphical and tabulated representations of the results 
      will be created for both descriptive and numerical results. The cost and 
      cost-effectiveness values will be presented as reported by the original studies 
      as well as converted into international dollars to allow comparability. As we are 
      predicting heterogenous results, we will conduct a narrative and interpretive 
      analysis of the data. ETHICS AND DISSEMINATION: No formal approval or review of 
      ethics is required for this systematic review as it will involve the collection 
      and analysis of secondary data. This protocol follows the current PRISMA-P 
      guidelines. The review will provide information on the cost and 
      cost-effectiveness of mHealth interventions targeting T2DM. These results will be 
      disseminated through publication and submission to conferences for presentations 
      and posters. PROSPERO REGISTRATION NUMBER: CRD42019123476.
CI  - (c) Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Rinaldi, Giulia
AU  - Rinaldi G
AUID- ORCID: 0000-0002-4212-4584
AD  - Medical Department, St George's University, London, Greater London, UK.
FAU - Hijazi, Alexa
AU  - Hijazi A
AD  - Institute for Global Health, University College London, London, UK.
FAU - Haghparast-Bidgoli, Hassan
AU  - Haghparast-Bidgoli H
AUID- ORCID: 0000-0001-6365-2944
AD  - Institute for Global Health, University College London, London, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190411
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Cost-Benefit Analysis
MH  - Diabetes Mellitus, Type 2/*prevention & control/*therapy
MH  - Humans
MH  - Research Design
MH  - Systematic Reviews as Topic
MH  - Telemedicine/*economics
PMC - PMC6500237
OTO - NOTNLM
OT  - general diabetes
OT  - health economics
OT  - telemedicine
COIS- Competing interests: None declared.
EDAT- 2019/04/13 06:00
MHDA- 2020/05/10 06:00
PMCR- 2019/04/11
CRDT- 2019/04/13 06:00
PHST- 2019/04/13 06:00 [entrez]
PHST- 2019/04/13 06:00 [pubmed]
PHST- 2020/05/10 06:00 [medline]
PHST- 2019/04/11 00:00 [pmc-release]
AID - bmjopen-2018-027490 [pii]
AID - 10.1136/bmjopen-2018-027490 [doi]
PST - epublish
SO  - BMJ Open. 2019 Apr 11;9(4):e027490. doi: 10.1136/bmjopen-2018-027490.